CROI 2019: Your day 3 recap

Promising New PrEP Findings and More: Dr. Dieffenbach’s HIV Research Highlights from Day 3 of CROI 2019 Findings on a new formulation of PrEP, studies that advance our understanding of the effects of inflammation associated with HIV infection, and a viewer’s question about HIV treatment as prevention were all topics addressed in our conversation with Dr. Carl Dieffenbach on the third day of CROI 2019.... LEARN MORE

Tuberculosis Diagnosis in People with HIV Increases Risk of Death Within 10 Years Among people with HIV in Latin America, those diagnosed with tuberculosis (TB) at an initial clinic visit were about twice as likely to die within 10 years as people not initially diagnosed with TB, according to findings from a large observational study reported at CROI 2019... LEARN MORE HIV-Related Immune Activation May Predict Weight Gain and Exacerbate Complications, Especially in Women These findings suggest that HIV-related weight gain and immune activation may amplify each other, especially in women... LEARN MORE